SGLT2 inhibitors and GLP1 agonists in Diabetes Type 2
Over the last few years, there have been significant breakthroughs in the management of Type 2 diabetes (T2D). Sodium–glucose...
Over the last few years, there have been significant breakthroughs in the management of Type 2 diabetes (T2D). Sodium–glucose...
Parkinson’s disease, the most common neurodegenerative movement disorder has growing prevalence with the age. Due to increasing life expectancy...